Publication | Open Access
Long-Term Complications of Radioligand Therapy with Lutetium-177 and Yttrium-90 in Patients with Neuroendocrine Neoplasms
13
Citations
19
References
2022
Year
Though low-grade complications of radioligand therapy are possible, it stay a safe method of NEN treatment where benefits outweigh the risk.
| Year | Citations | |
|---|---|---|
Page 1
Page 1